Not enough can be enough: feasibility of the Idylla

The minimally invasive procedures used in the diagnostic workup of patients with advanced non-small cell lung cancer (NSCLC) often provide poor yields of pathological material suitable for molecular analyses. Not infrequently, the DNA yield from small biopsies/cytological samples is insufficient for the assessment of genomic biomarkers that inform personalised therapies. The IdyllaTwenty NSCLC samples were selected accordingly toParallel assessment ofIEMT can provide remarkable diagnostic accuracy for the assessment of